| Value Based Long Term Care B Pc | |
|
5 Research Dr Ste 2 Shelton CT 06484-6288 | |
| (203) 567-5243 | |
| Not Available |
| Full Name | Value Based Long Term Care B Pc |
|---|---|
| Speciality | Internal Medicine |
| Location | 5 Research Dr Ste 2, Shelton, Connecticut |
| Authorized Official Name and Position | David Chess (OWNER) |
| Authorized Official Contact | 2034905869 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Value Based Long Term Care B Pc 5 Research Dr Ste 2 Shelton CT 06484-6288 Ph: (203) 567-5243 | Value Based Long Term Care B Pc 5 Research Dr Ste 2 Shelton CT 06484-6288 Ph: (203) 567-5243 |
| NPI Number | 1194498808 |
|---|---|
| Provider Enumeration Date | 07/28/2021 |
| Last Update Date | 07/28/2021 |
| Medicare PECOS PAC ID | 4082017884 |
|---|---|
| Medicare Enrollment ID | O20210729003709 |
News Archive
In a new study, researchers at Mount Sinai School of Medicine have taken a major step toward the ability to predict adverse drug reactions, using genetic, cellular, and clinical information to learn why some medicines cause heart arrhythmias in patients. Published in the April 20 issue of the journal Science Signaling, the new framework described in the study could potentially be applied to the study of medications that treat other diseases and disorders such as epilepsy and autism.
In FDLI's latest monograph, Selling Pharmaceuticals and Biologics to the Federal Government: Federal Supply Schedule and Federal Pricing Requirements, Joy Sturm, Allison Pugsley and Stephen A. Smyers of Hogan Lovells US LLP detail how pharmaceutical and biologics manufacturers can deal effectively with government contracting requirements and price calculation requirements.
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics.
Patients suffering from chronic obstructive pulmonary disease (COPD) typically suffer from depression more frequently than those without COPD, resulting in higher levels of disability and illness and increasing the overall healthcare burden for the COPD population.
Northwestern Medicine Prentice Women's Hospital and the Northwestern University Feinberg School of Medicine Department of Psychiatry is home to a landmark study that will, for the first time, take a close look at the impact of certain common antidepressants on pregnant women.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194498808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | (* (Not Available)) | Primary |
| Provider Name | David M Chess |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1376521773 PECOS PAC ID: 0749175404 Enrollment ID: I20180103001993 |
News Archive
In a new study, researchers at Mount Sinai School of Medicine have taken a major step toward the ability to predict adverse drug reactions, using genetic, cellular, and clinical information to learn why some medicines cause heart arrhythmias in patients. Published in the April 20 issue of the journal Science Signaling, the new framework described in the study could potentially be applied to the study of medications that treat other diseases and disorders such as epilepsy and autism.
In FDLI's latest monograph, Selling Pharmaceuticals and Biologics to the Federal Government: Federal Supply Schedule and Federal Pricing Requirements, Joy Sturm, Allison Pugsley and Stephen A. Smyers of Hogan Lovells US LLP detail how pharmaceutical and biologics manufacturers can deal effectively with government contracting requirements and price calculation requirements.
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics.
Patients suffering from chronic obstructive pulmonary disease (COPD) typically suffer from depression more frequently than those without COPD, resulting in higher levels of disability and illness and increasing the overall healthcare burden for the COPD population.
Northwestern Medicine Prentice Women's Hospital and the Northwestern University Feinberg School of Medicine Department of Psychiatry is home to a landmark study that will, for the first time, take a close look at the impact of certain common antidepressants on pregnant women.
› Verified 3 days ago
News Archive
In a new study, researchers at Mount Sinai School of Medicine have taken a major step toward the ability to predict adverse drug reactions, using genetic, cellular, and clinical information to learn why some medicines cause heart arrhythmias in patients. Published in the April 20 issue of the journal Science Signaling, the new framework described in the study could potentially be applied to the study of medications that treat other diseases and disorders such as epilepsy and autism.
In FDLI's latest monograph, Selling Pharmaceuticals and Biologics to the Federal Government: Federal Supply Schedule and Federal Pricing Requirements, Joy Sturm, Allison Pugsley and Stephen A. Smyers of Hogan Lovells US LLP detail how pharmaceutical and biologics manufacturers can deal effectively with government contracting requirements and price calculation requirements.
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics.
Patients suffering from chronic obstructive pulmonary disease (COPD) typically suffer from depression more frequently than those without COPD, resulting in higher levels of disability and illness and increasing the overall healthcare burden for the COPD population.
Northwestern Medicine Prentice Women's Hospital and the Northwestern University Feinberg School of Medicine Department of Psychiatry is home to a landmark study that will, for the first time, take a close look at the impact of certain common antidepressants on pregnant women.
› Verified 3 days ago
Value Based Long Term Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5 Research Dr Ste 2, Shelton, CT 06484 Phone: 781-343-1475 | |
Revival Iv And Wellness Clinic Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 12 Progress Dr Ste 1d, Shelton, CT 06484 Phone: 475-314-3011 Fax: 475-314-3011 | |
John Farens Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 224 Leavenworth Rd, Shelton, CT 06484 Phone: 203-926-1206 Fax: 203-926-0413 | |
H And B Quality Medical Care Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2 Ivy Brook Rd Ste 120, Shelton, CT 06484 Phone: 860-754-7407 | |
Advanced Pain And Regenerative Medical Solutions Corp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10 Progress Dr, Shelton, CT 06484 Phone: 203-948-8127 | |
St. Vincents Urgent Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 15 Armstrong Rd, Shelton, CT 06484 Phone: 203-929-1109 |